RECRUITING

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Autoimmune Liver disease Network for Kids (A-LiNK) is a multi-institutional group with the mission to deliver the best care to kids with pediatric autoimmune liver disease (AILD). This study will establish a shared clinical registry and a learning health network for the participating sites focusing on collecting and transmitting clinical measurement data, information about processes, and participation in an improvement collaborative. Pediatric Autoimmune Hepatitis (AIH) and Primary Sclerosing Cholangitis (PSC), represent a spectrum of AILD which present unique diagnostic and therapeutic challenges.A lack of accepted guidelines for disease monitoring or symptom management results in wide treatment variation with liver transplants indicated in refractory, progressive disease. The aims of A-LiNK are to: 1.) Create a learning health network focused on patient-centered outcomes research characterized by transparent sharing among centers, common priorities, and feasible plans for implementing new practices; 2) shift from traditional investigator-driven study to a patient and family-centered approach, and 3.) improve clinical outcomes and quality of life for pediatric AILD patients.

Official Title

Autoimmune Liver Disease Network for Kids (A-LiNK): Using Patient Data to Transform Care and Improve Outcomes for Children, Adolescents, and Young Adults With Autoimmune Liver Disease

Quick Facts

Study Start:2022-04-28
Study Completion:2033-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05750498

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Clinical diagnosis of autoimmune hepatitis (AIH)
  2. * Clinical diagnosis of primary sclerosing cholangitis (PSC)
  3. * Clinical diagnosis of autoimmune sclerosing cholangitis (ASC)
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Amy E Taylor, MD
CONTACT
513-636-4415
amy.taylor@cchmc.org
Cyd M Castro-Rojas, PhD
CONTACT
5135170580
cyd.castrorojas@cchmc.org

Principal Investigator

Amy E Taylor, MD
PRINCIPAL_INVESTIGATOR
Children's Hospital Medical Center, Cincinnati

Study Locations (Sites)

Stanford University
Palo Alto, California, 94304
United States
Riley Children's Health
Indianapolis, Indiana, 46202
United States
St. Louis Children's Hospital
Saint Louis, Missouri, 63110
United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229
United States
Nationwide Children's Hospital
Columbus, Ohio, 43205
United States
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224
United States
Seattle Children's Hospital
Seattle, Washington, 98105
United States

Collaborators and Investigators

Sponsor: Children's Hospital Medical Center, Cincinnati

  • Amy E Taylor, MD, PRINCIPAL_INVESTIGATOR, Children's Hospital Medical Center, Cincinnati

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-04-28
Study Completion Date2033-06-30

Study Record Updates

Study Start Date2022-04-28
Study Completion Date2033-06-30

Terms related to this study

Keywords Provided by Researchers

  • Pediatrics
  • Autoimmune Hepatitis
  • Primary Sclerosing Cholangitis
  • Autoimmune Sclerosing Cholangitis
  • Chronic Liver Disease
  • End-stage Liver Disease
  • Clinical Registry
  • Research Registry
  • Quality Improvement
  • Outcomes Research
  • Comparative Effectiveness Research
  • Patient Reported Outcomes
  • Health Services Research

Additional Relevant MeSH Terms

  • Autoimmune Hepatitis
  • Primary Sclerosing Cholangitis